SHOUCHENG (00697) invests in Arctic Strong Chip to promote the localization process in the field of full-scene real-time inference.
Shoucheng Holdings (00697) announced that recently, a company under Shoucheng Capital, a wholly-owned subsidiary of the group, has invested in Arctic Microelectronics Information Technology (Xi'an) Co., Ltd. (Arctic Microelectronics). This investment will effectively empower the core technology research and development and iterative upgrades of the invested enterprise, promoting the domestic substitution process in the field of all-scenario real-time inference.
SHOUCHENG (00697) announced that recently, a company under the group's subsidiary ShouCheng Capital (a wholly-owned subsidiary of the company) has invested in Arctic Fox Chip Technology (Xi'an) Co., Ltd. (Arctic Fox Chip). This investment will effectively empower the invested company's core technology research and development as well as iteration upgrades, promoting the domestic replacement process in the field of full-scenario real-time inference.
Arctic Fox Chip is dedicated to becoming an AI infrastructure service provider for large model applications. With its self-developed AI acceleration modules, chiplets, and 3D DRAM design, it provides low-cost, short delivery cycle comprehensive solutions for customers in large model inference application scenarios. This investment will inject strong development momentum into Arctic Fox Chip in key areas such as core product mass production delivery and technology iteration upgrades, helping it consolidate its core technological barriers and market competitive advantages.
The group will resolutely continue to increase its investment layout in cutting-edge technology, deepen strategic cooperation with high-quality companies in segmented industries, and promote the trend of China's AI infrastructure construction and domestic computing power ecology deployment through capital empowerment and industrial synergy. This will continuously drive the technological innovation and large-scale implementation of domestic computing power solutions, aiding the high-quality autonomous and controllable development of China's computing power industry.
Related Articles

Tcl Corporation (000100.SZ) has received approval from the China Securities Regulatory Commission for its share issuance and acquisition.

HIGH FASHION (00608) issues a profit warning, expecting that interim profits will decrease by approximately 45% to 65% compared to the same period last year.

LEADS BIOLABS-B(09887): The summary of the Phase II clinical study of Vilex (Opalimab, a PD-L1/4-1BB bispecific antibody, LBL-024) as a first-line treatment for NSCLC has been published on the WCLC website.
Tcl Corporation (000100.SZ) has received approval from the China Securities Regulatory Commission for its share issuance and acquisition.

HIGH FASHION (00608) issues a profit warning, expecting that interim profits will decrease by approximately 45% to 65% compared to the same period last year.

LEADS BIOLABS-B(09887): The summary of the Phase II clinical study of Vilex (Opalimab, a PD-L1/4-1BB bispecific antibody, LBL-024) as a first-line treatment for NSCLC has been published on the WCLC website.

RECOMMEND





